Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
3.510
-0.010 (-0.28%)
Mar 14, 2025, 12:35 PM EDT - Market open
Iovance Biotherapeutics Employees
Iovance Biotherapeutics had 838 employees as of December 31, 2024. The number of employees increased by 281 or 50.45% compared to the previous year.
Employees
838
Change (1Y)
281
Growth (1Y)
50.45%
Revenue / Employee
$195,788
Profits / Employee
-$444,125
Market Cap
1.15B
Employees Chart
IOVA News
- 13 days ago - Iovance's Q4: Execution Risks Mount As Infusion Growth Slows (Rating Downgrade) - Seeking Alpha
- 14 days ago - Iovance Biotherapeutics, Inc. (IOVA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024 - GlobeNewsWire
- 23 days ago - Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025 - GlobeNewsWire
- 4 weeks ago - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer - GlobeNewsWire
- 2 months ago - Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025 - Seeking Alpha
- 2 months ago - Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market - CNBC